Specific antibodies for baff

Abstract

The present invention relates to anti-BLyS antigen-binding proteins, such as an anti-BLyS antibody capable of antagonizing BLyS. The invention also relates to nucleic acid sequences encoding the antigen-binding protein, and to the use of the antigen-binding protein in therapy, for example, in diseases where B cells play a pathogenic role, such as autoimmune diseases, chronic inflammatory diseases, and / or cancer.